ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation

In chronic lymphocytic leukemia (CLL), TP53 gene defects, due to deletion of the 17p13 locus and/or mutation(s) within the TP53 gene, are associated with resistance to chemoimmunotherapy and a particularly dismal clinical outcome. On these grounds, analysis of TP53 aberrations has been incorporated...

Descripción completa

Detalles Bibliográficos
Autores principales: Malcikova, J., Tausch, E., Rossi, D., Sutton, L. A., Soussi, T., Zenz, T., Kater, A. P., Niemann, C. U., Gonzalez, D., Davi, F., Gonzalez Diaz, M., Moreno, C., Gaidano, G., Stamatopoulos, K., Rosenquist, R., Stilgenbauer, S., Ghia, P., Pospisilova, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940638/
https://www.ncbi.nlm.nih.gov/pubmed/29467486
http://dx.doi.org/10.1038/s41375-017-0007-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940638/
https://www.ncbi.nlm.nih.gov/pubmed/29467486
http://dx.doi.org/10.1038/s41375-017-0007-7

Ejemplares similares